Markets:

Overview

News

Currencies

International

Treasuries

10x Genomics, Inc. - Common Stock (NQ:TXG)

21.09 -0.53 (-2.45%)

Streaming Delayed Price Updated: 3:46 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about 10x Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 07, 2025

Via Benzinga

10X Genomics (NASDAQ:TXG) Surges 13% on Q3 Revenue Beat and Strong Guidance ↗

November 06, 2025

10x Genomics (TXG) stock surged over 13% after beating Q3 2025 earnings estimates and providing strong Q4 revenue guidance, signaling investor optimism.

Via Chartmill

10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1%

November 06, 2025

Biotech company 10x Genomics (NASDAQ:TXG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s...

Via StockStory

Mark Zuckerberg’s Chan Zuckerberg Initiative Bets Big on AI to Conquer All Diseases

November 06, 2025

The Chan Zuckerberg Initiative (CZI), founded by Priscilla Chan and Mark Zuckerberg, is placing artificial intelligence at the very heart of its audacious mission: to cure, prevent, or manage all...

Via TokenRing AI

Topics Artificial Intelligence

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Analyst Expectations For 10x Genomics's Future ↗

October 23, 2025

Via Benzinga

10x Genomics Earnings: What To Look For From TXG

November 04, 2025

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting results this Thursday after market hours. Here’s what investors should know.

Via StockStory

Lancaster Opens $7 Million Position in 10x Genomics (TXG) ↗

October 24, 2025

Lancaster Opens $7 Million Position in 10x Genomics (TXG)

Via The Motley Fool

3 Healthcare Stocks Walking a Fine Line

October 24, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

10x Genomics Partners With Anthropic To Bring AI Tools For Researchers ↗

October 20, 2025

10x Genomics is partnering with Anthropic to integrate its single cell and spatial biology analysis tools into Claude for Life Sciences.

Via Stocktwits

Topics Artificial Intelligence

Why Is 10x Genomics (TXG) Stock Rocketing Higher Today

October 20, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6% in the morning session after BofA Securities maintained its "Buy" rating on the stock, even while lowering its price target.

Via StockStory

Topics Artificial Intelligence

Why 10x Genomics (TXG) Stock Is Trading Up Today

October 15, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 1.5% in the afternoon session after it announced a strategic partnership with SPT Labtech, a laboratory automation company, to provide...

Via StockStory

Topics Economy Government World Trade

Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns ↗

October 15, 2025

Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.

Via Benzinga

Topics Artificial Intelligence

3 Unprofitable Stocks with Questionable Fundamentals

October 13, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Topics Artificial Intelligence

10x Genomics, BioMarin Pharmaceutical, AMN Healthcare Services, Illumina, and Moderna Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗

September 18, 2025

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue.

Via Benzinga

3 Stocks Under $50 We Find Risky

September 16, 2025

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...

Via StockStory

10x Genomics (TXG) Stock Trades Down, Here Is Why

September 12, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) fell 2.4% in the afternoon session after the stock extended its negative momentum as Piper Sandler initiated coverage of the stock with a Neutral...

Via StockStory

Topics Artificial Intelligence

10x Genomics (TXG) Stock Is Up, What You Need To Know

September 11, 2025

Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 2.1% in the morning session after Piper Sandler initiated coverage on the stock with a Neutral rating and a $15.00 price target.

Via StockStory

Topics Economy

Expert Outlook: 10x Genomics Through The Eyes Of 6 Analysts ↗

September 11, 2025

Via Benzinga

This Eaton Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

September 11, 2025

Via Benzinga

2 Cash-Heavy Stocks to Own for Decades and 1 We Turn Down

September 11, 2025

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits,...

Via StockStory

Boston Scientific, U.S. Physical Therapy, 10x Genomics, GE HealthCare, and Integer Holdings Shares Are Falling, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy Government Law Enforcement

1 Small-Cap Stock with Impressive Fundamentals and 2 We Question

August 26, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

Powering Progress: AI's Insatiable Energy Appetite and Biotech's Dual Dawn

August 27, 2025

The global economy in 2025 is navigating a landscape profoundly reshaped by the escalating demands of Artificial Intelligence (AI) and transformative shifts in healthcare. While the burgeoning energy...

Via MarketMinute

Topics Artificial Intelligence Economy Emissions

Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks

August 24, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the life sciences tools & services stocks, including 10x Genomics (NASDAQ:TXG) and its peers.

Via StockStory

Topics Artificial Intelligence Economy

Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics Economy

LGI Homes, Moderna, Fortrea, 10x Genomics, and Cogent Shares Are Falling, What You Need To Know

August 21, 2025

A number of stocks fell in the afternoon session after markets continued to decline, as investors grew cautious ahead of a key speech by Federal Reserve Chair Jerome Powell. The move came as U.S....

Via StockStory

Topics Economy Stocks

1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down

August 20, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Topics Bonds

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.